Molecular Medicine

, Volume 18, Issue 3, pp 528–538 | Cite as

Implication of the miR-184 and miR-204 Competitive RNA Network in Control of Mouse Secondary Cataract

  • Andrea Hoffmann
  • Yusen Huang
  • Rinako Suetsugu-Maki
  • Carol S Ringelberg
  • Craig R Tomlinson
  • Katia Del Rio-Tsonis
  • Panagiotis A Tsonis
Research Article


The high recurrence rate of secondary cataract (SC) is caused by the intrinsic differentiation activity of residual lens epithelial cells after extra-capsular lens removal. The objective of this study was to identify changes in the microRNA (miRNA) expression profile during mouse SC formation and to selectively manipulate miRNA expression for potential therapeutic intervention. To model SC, mouse cataract surgery was performed and temporal changes in the miRNA expression pattern were determined by microarray analysis. To study the potential SC counterregulative effect of miRNAs, a lens capsular bag in vitro model was used. Within the first 3 wks after cataract surgery, microarray analysis demonstrated SC-associated expression pattern changes of 55 miRNAs. Of the identified miRNAs, miR-184 and miR-204 were chosen for further investigations. Manipulation of miRNA expression by the miR-184 inhibitor (anti-miR-184) and the precursor miRNA for miR-204 (pre-miR-204) attenuated SC-associated expansion and migration of lens epithelial cells and signs of epithelial to mesenchymal transition such as α-smooth muscle actin expression. In addition, pre-miR-204 attenuated SC-associated expression of the transcription factor Meis homeobox 2 (MEIS2). Examination of miRNA target binding sites for miR-184 and miR-204 revealed an extensive range of predicted target mRNA sequences that were also a target to a complex network of other SC-associated miRNAs with possible opposing functions. The identification of the SC-specific miRNA expression pattern together with the observed in vitro attenuation of SC by anti-miR-184 and pre-miR-204 suggest that miR-184 and miR-204 play a significant role in the control of SC formation in mice that is most likely regulated by a complex competitive RNA network.



This work was supported by National Institutes of Health grant EY16707 to PA Tsonis.

Supplementary material

10020_2012_1803528_MOESM1_ESM.pdf (579 kb)
Implication of the miR-184 and miR-204 Competitive RNA Network in Control of Mouse Secondary Cataract


  1. 1.
    Li Z, Cui H, Zhang L, Liu P, Bai J. (2009) Prevalence of and associated factors for corneal blindness in a rural adult population (the southern Harbin eye study). Curr. Eye Res. 34:646–51.CrossRefGoogle Scholar
  2. 2.
    Klein BE, Klein R, Linton KL. (1992) Prevalence of age-related lens opacities in a population: The Beaver Dam Eye Study. Ophthalmology. 99:546–52.CrossRefGoogle Scholar
  3. 3.
    Blakely EA, et al. (2010) Radiation cataractogenesis: epidemiology and biology. Radiat. Res. 173:709–17.CrossRefGoogle Scholar
  4. 4.
    Davies MJ, Truscott RJ. (2001) Photo-oxidation of proteins and its role in cataractogenesis. J. Photochem. Photobiol. B. 63:114–25.CrossRefGoogle Scholar
  5. 5.
    Shiels A, Bennett TM, Hejtmancik JF. (2010) Cat-Map: putting cataract on the map. Mol Vis 16:2007–15.PubMedPubMedCentralGoogle Scholar
  6. 6.
    Rao GN, Khanna R, Payal A. (2011) The global burden of cataract. Curr. Opin. Ophthalmol. 22:4–9.CrossRefGoogle Scholar
  7. 7.
    Saika S, et al. (2009) TGF beta in fibroproliferative diseases in the eye. Front. Biosci. (Schol. Ed.). 1:376–90.CrossRefGoogle Scholar
  8. 8.
    Clark JI, Matsushima H, David LL, Clark JM. (1999) Lens cytoskeleton and transparency: a model. Eye (Lond.). 13:417–24.CrossRefGoogle Scholar
  9. 9.
    Ihanamaki T, Pelliniemi LJ, Vuorio E. (2004) Collagens and collagen-related matrix components in the human and mouse eye. Prog. Retin. Eye Res. 23:403–34.CrossRefGoogle Scholar
  10. 10.
    Saika S, et al. (2008) Fibrotic disorders in the eye: targets of gene therapy. Prog. Retin. Eye Res. 27:177–96.CrossRefGoogle Scholar
  11. 11.
    Cvekl A, Mitton KP. (2010) Epigenetic regulatory mechanisms in vertebrate eye development and disease. Heredity. 105:135–51.CrossRefGoogle Scholar
  12. 12.
    Call MK, Grogg MW, Del Rio-Tsonis K, Tsonis PA. (2004) Lens regeneration in mice: implications in cataracts. Exp. Eye Res. 78:297–9.CrossRefGoogle Scholar
  13. 13.
    Suetsugu-Maki R, et al. (2011) A complement receptor C5a antagonist regulates epithelial to mesenchymal transition and crystallin expression after lens cataract surgery in mice. Mol. Vis. 17:949–64.PubMedPubMedCentralGoogle Scholar
  14. 14.
    Lois N, et al. (2005) Effect of TGF-beta2 and anti-TGF-beta2 antibody in a new in vivo rodent model of posterior capsule opacification. Invest. Ophthalmol. Vis. Sci. 46:4260–6.CrossRefGoogle Scholar
  15. 15.
    Nakamura K, et al. (2010) miRNAs in newt lens regeneration: specific control of proliferation and evidence for miRNA networking. PLoS One. 5:e12058.CrossRefGoogle Scholar
  16. 16.
    Ambros V. (2004) The functions of animal microRNAs. Nature. 431:350–5.CrossRefGoogle Scholar
  17. 17.
    Bartel DP. (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 116:281–97.CrossRefGoogle Scholar
  18. 18.
    Kaucsar T, Racz Z, Hamar P. (2010) Post-transcriptional gene-expression regulation by micro RNA (miRNA) network in renal disease. Adv. Drug Deliv. Rev. 62:1390–401.CrossRefGoogle Scholar
  19. 19.
    Hinkel R, Trenkwalder T, Kupatt C. (2011) Gene therapy for ischemic heart disease. Expert Opin. Biol. Ther. 11:723–37.CrossRefGoogle Scholar
  20. 20.
    Oba S, et al. (2010) miR-200b precursor can ameliorate renal tubulointerstitial fibrosis. PLoS One. 5:e13614.CrossRefGoogle Scholar
  21. 21.
    Park HY, et al. (2010) Effects of nuclear factor-kappaB small interfering RNA on posterior capsule opacification. Invest. Ophthalmol. Vis. Sci. 51:4707–15.CrossRefGoogle Scholar
  22. 22.
    Medvedovic M, Tomlinson CR, Call MK, Grogg M, Tsonis PA. (2006) Gene expression and discovery during lens regeneration in mouse: regulation of epithelial to mesenchymal transition and lens differentiation. Mol. Vis. 12:422–40.PubMedGoogle Scholar
  23. 23.
    Trask HW, et al. (2009) Microarray analysis of cytoplasmic versus whole cell RNA reveals a considerable number of missed and false positive mRNAs. RNA. 15:1917–28.CrossRefGoogle Scholar
  24. 24.
    Zahurak M, et al. (2007) Pre-processing Agilent microarray data. BMC Bioinformatics. 8:142.CrossRefGoogle Scholar
  25. 25.
    Ryan DG, Oliveira-Fernandes M, Lavker RM. (2006) MicroRNAs of the mammalian eye display distinct and overlapping tissue specificity. Mol. Vis. 12:1175–84.PubMedGoogle Scholar
  26. 26.
    Shen J, et al. (2008) MicroRNAs regulate ocular neovascularization. Mol. Ther. 16:1208–16.CrossRefGoogle Scholar
  27. 27.
    Tsonis PA, et al. (2007) MicroRNAs and regeneration: Let-7 members as potential regulators of dedifferentiation in lens and inner ear hair cell regeneration of the adult newt. Biochem. Biophys. Res. Commun. 362:940–5.CrossRefGoogle Scholar
  28. 28.
    Frederikse PH, Donnelly R, Partyka LM. (2006) miRNA and Dicer in the mammalian lens: expression of brain-specific miRNAs in the lens. Histochem. Cell. Biol. 126:1–8.CrossRefGoogle Scholar
  29. 29.
    Tian L, Huang K, DuHadaway JB, Prendergast GC, Stambolian D. (2010) Genomic profiling of miRNAs in two human lens cell lines. Curr. Eye Res. 35:812–8.CrossRefGoogle Scholar
  30. 30.
    Kutty RK, et al. (2010) MicroRNA expression in human retinal pigment epithelial (ARPE-19) cells: increased expression of microRNA-9 by N-(4-hydroxyphenyl)retinamide. Mol. Vis. 16:1475–86.PubMedPubMedCentralGoogle Scholar
  31. 31.
    Gessert S, Bugner V, Tecza A, Pinker M, Kuhl M. (2010) FMR1/FXR1 and the miRNA pathway are required for eye and neural crest development. Dev. Biol. 341:222–35.CrossRefGoogle Scholar
  32. 32.
    Ting Y, Medina DJ, Strair RK, Schaar DG. (2010) Differentiation-associated miR-22 represses Max expression and inhibits cell cycle progression. Biochem. Biophys. Res. Commun. 394:606–11.CrossRefGoogle Scholar
  33. 33.
    Wang Q, et al. (2008) MicroRNA miR-24 inhibits erythropoiesis by targeting activin type I receptor ALK4. Blood. 111:588–95.CrossRefGoogle Scholar
  34. 34.
    Sun Q, et al. (2008) Transforming growth factor-beta-regulated miR-24 promotes skeletal muscle differentiation. Nucleic Acids Res. 36:2690–9.CrossRefGoogle Scholar
  35. 35.
    Chan MC, et al. (2010) Molecular basis for antagonism between PDGF and the TGFbeta family of signalling pathways by control of miR-24 expression. EMBO J. 29:559–73.CrossRefGoogle Scholar
  36. 36.
    Cheng AM, Byrom MW, Shelton J, Ford LP. (2005) Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res. 33:1290–7.CrossRefGoogle Scholar
  37. 37.
    Hoover LL, Kubalak SW. (2008) Holding their own: the noncanonical roles of Sad proteins. Sci. Signal. 1:pe48CrossRefGoogle Scholar
  38. 38.
    Liu G, et al. (2010) miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis. J. Exp. Med. 207:1589–97.CrossRefGoogle Scholar
  39. 39.
    Yao Q, et al. (2011) Micro-RNA-21 regulates TGF-beta-induced myofibroblast differentiation by targeting PDCD4 in tumor-stroma interaction. Int. J. Cancer. 128:1783–92.CrossRefGoogle Scholar
  40. 40.
    Wang Y, Lee CG. (2009) MicroRNA and cancer: focus on apoptosis. J. Cell. Mol. Med. 13:12–23.CrossRefGoogle Scholar
  41. 41.
    Ozcan S. (2009) MiR-30 family and EMT in human fetal pancreatic islets. Islets. 1:283–5.CrossRefGoogle Scholar
  42. 42.
    Duisters RF, et al. (2009) miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling. Circ. Res. 104:170–8.CrossRefGoogle Scholar
  43. 43.
    Joglekar MV, et al. (2009) The miR-30 family microRNAs confer epithelial phenotype to human pancreatic cells. Islets. 1:137–47.CrossRefGoogle Scholar
  44. 44.
    Wormstone IM, Wang L, Liu CS. (2009) Posterior capsule opacification. Exp. Eye Res. 88:257–69.CrossRefGoogle Scholar
  45. 45.
    Conte I, et al. miR-204 is required for lens and retinal development via Meis2 targeting. Proc. Natl. Acad. Sci. U. S. A. 107:15491–6.CrossRefGoogle Scholar
  46. 46.
    Hughes AE, et al. (2011) Mutation altering the miR-184 seed region causes familial keratoconus with cataract. Am. J. Hum. Genet. 89:628–33.CrossRefGoogle Scholar
  47. 47.
    Conte I, et al. (2010) miR-204 is required for lens and retinal development via Meis2 targeting. Proc. Natl. Acad. Sci. U. S. A. 107:15491–6.CrossRefGoogle Scholar
  48. 48.
    Huang J, Zhao L, Xing L, Chen D. (2010) Micro-RNA-204 regulates Runx2 protein expression and mesenchymal progenitor cell differentiation. Stem Cells. 28:357–64.PubMedPubMedCentralGoogle Scholar
  49. 49.
    Zhang X, Friedman A, Heaney S, Purcell P, Maas RL. (2002) Meis homeoproteins directly regulate Pax6 during vertebrate lens morphogenesis. Genes. Dev. 16:2097–107.CrossRefGoogle Scholar
  50. 50.
    Ramalingam A, et al. (2008) Bin3 deletion causes cataracts and increased susceptibility to lymphoma during aging. Cancer Res. 68:1683–90.CrossRefGoogle Scholar
  51. 51.
    Bumsted-O’Brien KM, Hendrickson A, Haverkamp S, Ashery-Padan R, Schulte D. (2007) Expression of the homeodomain transcription factor Meis2 in the embryonic and postnatal retina. J. Comp. Neurol. 505:58–72.CrossRefGoogle Scholar
  52. 52.
    Heine P, Dohle E, Bumsted-O’Brien K, Engelkamp D, Schulte D. (2008) Evidence for an evolutionary conserved role of homothorax/Meis1/2 during vertebrate retina development. Development. 135:805–11.CrossRefGoogle Scholar
  53. 53.
    Karali M, et al. (2010) miRNeye: a microRNA expression atlas of the mouse eye. BMC Genomics. 11:715.CrossRefGoogle Scholar
  54. 54.
    Kuokkanen S, et al. (2010) Genomic profiling of microRNAs and messenger RNAs reveals hormonal regulation in microRNA expression in human endometrium. Biol. Reprod. 82:791–801.CrossRefGoogle Scholar
  55. 55.
    Arora A, et al. (2010) Prediction of microRNAs affecting mRNA expression during retinal development. BMC Dev. Biol. 10:1.CrossRefGoogle Scholar
  56. 56.
    Hemida MG, Ye X, Thair S, Yang D. (2010) Exploiting the therapeutic potential of microRNAs in viral diseases: expectations and limitations. Mol. Diagn. Ther. 14:271–82.CrossRefGoogle Scholar
  57. 57.
    Jamaluddin MS, et al. (2011) miRNAs: roles and clinical applications in vascular disease. Expert Rev. Mol. Diagn. 11:79–89.CrossRefGoogle Scholar
  58. 58.
    Gandellini P, Profumo V, Folini M, Zaffaroni N. (2011) MicroRNAs as new therapeutic targets and tools in cancer. Expert Opin. Ther. Targets. 15:265–79.CrossRefGoogle Scholar
  59. 59.
    Jiang X, Tsitsiou E, Herrick SE, Lindsay MA. (2010) MicroRNAs and the regulation of fibrosis. FEBS J. 277:2015–21.CrossRefGoogle Scholar
  60. 60.
    Christensen AK, Jensen AM. (2008) Tissuespecific requirements for specific domains in the FERM protein Moe/Epb4.1l5 during early zebrafish development. BMC Dev. Biol. 8:3.CrossRefGoogle Scholar
  61. 61.
    Horng S, et al. (2009) Differential gene expression in the developing lateral geniculate nucleus and medial geniculate nucleus reveals novel roles for Zic4 and Foxp2 in visual and auditory pathway development. J. Neurosci. 29:13672–83.CrossRefGoogle Scholar
  62. 62.
    Hirano M, Hashimoto S, Yonemura S, Sabe H, Aizawa S. (2008) EPB41L5 functions to post-transcriptionally regulate cadherin and integrin during epithelial-mesenchymal transition. J. Cell. Biol. 182:1217–30.CrossRefGoogle Scholar
  63. 63.
    Hisa T, et al. (2004) Hematopoietic, angiogenic and eye defects in Meis1 mutant animals. EMBO J. 23:450–9.CrossRefGoogle Scholar
  64. 64.
    Wan X, et al. (2010) Negative feedback regulation of Wnt4 signaling by EAF1 and EAF2/U19. PLoS One. 5:e9118.CrossRefGoogle Scholar
  65. 65.
    Acharya M, Huang L, Fleisch VC, Allison WT, Walter MA. (2011) A complex regulatory network of transcription factors critical for ocular development and disease. Hum. Mol. Genet. 20:1610–24.CrossRefGoogle Scholar
  66. 66.
    Fang X, et al. Landscape of the SOX2 proteinprotein interactome. Proteomics. 11:921–934.CrossRefGoogle Scholar
  67. 67.
    Al-Dosari MS, et al. (2010) Ocular manifestations of branchio-oculo-facial syndrome: report of a novel mutation and review of the literature. Mol. Vis. 16:813–8.PubMedPubMedCentralGoogle Scholar
  68. 68.
    Lecoin L, Sii-Felice K, Pouponnot C, Eychene A, Felder-Schmittbuhl MP. (2004) Comparison of maf gene expression patterns during chick embryo development. Gene Expr. Patterns. 4:35–46.CrossRefGoogle Scholar
  69. 69.
    Wurm A, Sock E, Fuchshofer R, Wegner M, Tamm ER. (2008) Anterior segment dysgenesis in the eyes of mice deficient for the high-mobility-group transcription factor Sox11. Exp. Eye Res. 86:895–907.CrossRefGoogle Scholar
  70. 70.
    Vieira V, et al. (2008) Differential regulation of Dlg1, Scrib, and Lgl1 expression in a transgenic mouse model of ocular cancer. Mol. Vis. 14:2390–403.PubMedPubMedCentralGoogle Scholar
  71. 71.
    Nguyen MM, et al.(2003) Requirement of PDZ-containing proteins for cell cycle regulation and differentiation in the mouse lens epithelium. Mol. Cell. Biol. 23:8970–81.CrossRefGoogle Scholar
  72. 72.
    Osada H, et al. (2011) Ultraviolet B-induced expression of amphiregulin and growth differentiation factor 15 in human lens epithelial cells. Mol. Vis. 17:159–69.PubMedPubMedCentralGoogle Scholar
  73. 73.
    Tuccoli A, Poliseno L, Rainaldi G. (2006) miRNAs regulate miRNAs: coordinated transcriptional and post-transcriptional regulation. Cell Cycle 5:2473–6.CrossRefGoogle Scholar
  74. 74.
    Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP. (2011) A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell. 146:353–8.CrossRefGoogle Scholar
  75. 75.
    Seitz H. (2009) Redefining microRNA targets. Curr. Biol. 19:870–3.CrossRefGoogle Scholar

Copyright information

© The Author(s) 2012

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, and provide a link to the Creative Commons license. You do not have permission under this license to share adapted material derived from this article or parts of it.

The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

To view a copy of this license, visit (

Authors and Affiliations

  • Andrea Hoffmann
    • 1
  • Yusen Huang
    • 1
  • Rinako Suetsugu-Maki
    • 1
  • Carol S Ringelberg
    • 2
  • Craig R Tomlinson
    • 2
  • Katia Del Rio-Tsonis
    • 3
  • Panagiotis A Tsonis
    • 1
  1. 1.Department of Biology and Center for Tissue Regeneration and Engineering at Dayton (TREND)University of DaytonDaytonUSA
  2. 2.Department of Medicine and Department of Pharmacology and ToxicologyDartmouth Hitchcock Medical Center, Dartmouth CollegeLebanonUSA
  3. 3.Department of ZoologyMiami UniversityOxfordUSA

Personalised recommendations